Hangzhou Xinci Technology Co., Ltd.

Xinci Technology was founded in May 2016. It is a high-tech medical device company specializing in the research and development, production and sales of high-end medical equipment with biomagnetic technology. It has long been deeply involved in new cardiovascular disease diagnosis technologies. Relying on the cutting-edge exploration of quantum sensing technology in biomagnetic imaging, it has built a series of products including magnetocardiograph, A comprehensive product system including atomic magnetometer sensors, magnetic shielding equipment and cardiac magnetic imaging analysis software, provides a series of products based on quantum precision measurement technology (atomic magnetometer) to detect cardiac biomagnetism, and is committed to the development of non-radiation, non-contact, non-invasive equipment for clinical diagnosis of heart diseases. Xinci Technology is developing in the direction of collectivization. It has established Chongqing as its production, warehousing and exhibition base, Hangzhou product research and development base, and Beijing product marketing and medical promotion base. It aims to integrate product research and development, manufacturing, clinical application, marketing and other resources, with a view to growing into an internationally leading biomagnetic medical high-tech enterprise. 1. Core business The company focuses on magnetocardiograph products and provides R&D, design, manufacturing and sales services for the entire industry chain from core components VCSEL laser chips, atomic gas chambers, atomic magnetometer sensor components, shielding tube equipment, magnetocardiograph image analysis software to magnetocardiographs. The main products include magnetocardiographs, 3D magnetocardiographs, atomic magnetometers, shielding tube equipment, etc. The company's magnetocardiograph product (QBM-C2049) has been strictly inspected by the Zhejiang Provincial Medical Device Inspection Institute, completed animal experiments, clinically verified by the multi-center national medical device clinical trial institution, and passed by the Zhejiang Provincial Medical Device Evaluation Center